<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23589894</PMID>
<DateCompleted>
<Year>2013</Year>
<Month>06</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1091-6490</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>110</Volume>
<Issue>18</Issue>
<PubDate>
<Year>2013</Year>
<Month>Apr</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
<ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
</Journal>
<ArticleTitle>Murine natural killer cell licensing and regulation by T regulatory cells in viral responses.</ArticleTitle>
<Pagination>
<MedlinePgn>7401-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1218767110</ELocationID>
<Abstract>
<AbstractText>Natural killer (NK) cells show differential functionality based on their capability of binding to self-MHC consistent with licensing. Here we show in vivo confirmation of the physiologic effects of licensing with differential effects of NK subsets on anti-murine cytomegalovirus (anti-MCMV) responses after syngeneic hematopoietic stem cell transplantation (HSCT) or regulatory T-cell (Treg) depletion. After HSCT, depletion of licensed NK cells led to far greater viral loads in target organs early after infection compared with nondepleted and unlicensed depleted mice. There was a preferential expansion of licensed, C-type lectin-like activating receptor Ly49H+ NK cells with increased IFNγ production after infection in nondepleted mice post-HSCT and after Treg depletion. Adoptive transfer of licensed NK subsets into immunodeficient hosts provided significantly greater MCMV resistance compared with transfer of total NK populations or unlicensed subsets. In non-HSCT mice, only concurrent depletion of Tregs or TGF-β neutralization resulted in detection of NK licensing effects. This suggests that licensed NK cells are the initial and rapidly responding population of NK cells to MCMV infection, but are highly regulated by Tregs and TGF-β.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sungur</LastName>
<ForeName>Can M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Department of Dermatology, University of California at Davis, Sacramento, CA 95817, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tang-Feldman</LastName>
<ForeName>Yajarayma J</ForeName>
<Initials>YJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ames</LastName>
<ForeName>Erik</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Alvarez</LastName>
<ForeName>Maite</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Mingyi</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Longo</LastName>
<ForeName>Dan L</ForeName>
<Initials>DL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pomeroy</LastName>
<ForeName>Claire</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Murphy</LastName>
<ForeName>William J</ForeName>
<Initials>WJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 HL089905</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>04</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
<NlmUniqueID>7505876</NlmUniqueID>
<ISSNLinking>0027-8424</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D055650">NK Cell Lectin-Like Receptor Subfamily A</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>82115-62-6</RegistryNumber>
<NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019264">Adoptive Transfer</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049109">Cell Proliferation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018380">Hematopoietic Stem Cell Transplantation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006566">Herpesviridae Infections</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000821">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007371">Interferon-gamma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007694">Killer Cells, Natural</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008212">Lymphocyte Depletion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020297">Mice, Congenic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018146">Muromegalovirus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055650">NK Cell Lectin-Like Receptor Subfamily A</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050378">T-Lymphocytes, Regulatory</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016212">Transforming Growth Factor beta</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp; inhibitors</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019562">Viral Load</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2013</Year>
<Month>6</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">23589894</ArticleId>
<ArticleId IdType="pii">1218767110</ArticleId>
<ArticleId IdType="doi">10.1073/pnas.1218767110</ArticleId>
<ArticleId IdType="pmc">PMC3645578</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Blood. 2005 Apr 15;105(8):3051-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15632206</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2004 Nov 26;306(5701):1517-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15567854</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2005 Jun 1;105(11):4416-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15728129</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2005 Aug 4;436(7051):709-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16079848</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2005 Oct 17;202(8):1075-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16230475</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol Methods. 2006 Feb;131(2):122-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16140399</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2006 Mar 15;176(6):3301-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16517695</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5460-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16567639</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Immunol. 2006 Sep;36(9):2324-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16933362</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2007 Nov 1;179(9):5977-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17947671</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2008 Feb 1;180(3):1556-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18209051</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3053-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18287063</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Rev. 2008 Aug;224:85-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18759922</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Immunopathol. 2008 Dec;30(4):425-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18949477</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2009 Apr 15;182(8):4572-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19342631</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Immunol. 2009 Apr;30(4):143-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19282243</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2009 Aug 1;183(3):1789-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19587011</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2009 Sep 1;183(5):2911-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19648279</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2009 Sep 28;206(10):2235-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19720840</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2010 Apr;11(4):321-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20190757</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2010 Dec 1;70(23):9554-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20935224</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2011 May 9;208(5):1105-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21518798</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2011 Jun 30;117(26):7032-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21498673</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2011 Aug;7(8):e1002141</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21829360</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Blood Marrow Transplant. 2011 Nov;17(11):1679-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21664472</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Mol Med. 2011 Nov;17(11):677-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21852192</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2012 Feb 9;119(6):1590-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22184406</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2012 Mar 1;188(5):2218-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22287714</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2012 Mar 15;119(11):2665-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22180440</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2012 Sep;122(9):3260-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22863621</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2013 Apr 4;121(14):2678-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23325834</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2009 Mar 12;113(11):2434-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18974374</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol Methods. 2000 Sep;89(1-2):61-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10996640</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Immunol. 2001;19:291-330</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11244039</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Invest. 2002;20(3):405-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12025235</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 1987 Dec;23(4):393-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2826680</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 1993 Sep;168(3):725-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8394863</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 1995;140(5):853-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7605198</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Immunol. 1998;16:359-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9597134</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunity. 1999 Jul;11(1):67-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10435580</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2005 Apr 4;201(7):1145-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15809355</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>